Mechanism of non-thermal atmospheric plasma in anti-tumor: influencing intracellular RONS and regulating signaling

Wenjie Wang1,2, Peijia Zheng1,2, Liang Yan1,2

  • 1Department of Stomatology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

PubMed

Insights

Non-thermal atmospheric plasma (NTAP) effectively combats tumors by inducing cell death and inhibiting growth. This review clarifies how NTAP generates reactive oxygen and nitrogen species (RONS) to trigger anti-tumor pathways.

Area of Science:

  • Biomedical Engineering
  • Plasma Physics
  • Cancer Research

Background:

  • Non-thermal atmospheric plasma (NTAP) exhibits significant anti-tumor properties, including inhibition of proliferation and metastasis, and promotion of apoptosis.
  • Reactive oxygen species (ROS) and reactive nitrogen species (RNS) are recognized as key NTAP effector components, but their precise anti-tumor mechanisms require systematic elucidation.

Purpose of the Study:

  • To systematically summarize the mechanisms underlying NTAP's anti-tumor effects.
  • To elucidate how NTAP influences intracellular reactive oxygen and nitrogen species (RONS) concentrations.
  • To detail the dysregulation of key signaling pathways (NRF2, PI3K, MAPK, NF-κB) induced by RONS and their link to anti-tumor outcomes.

Main Methods:

  • Literature review and synthesis of existing research on NTAP and cancer.
  • Analysis of mechanisms for NTAP-induced RONS generation.
  • Examination of RONS-mediated signaling pathway alterations in tumor cells.

Main Results:

  • NTAP treatment leads to increased intracellular RONS concentration through direct and indirect mechanisms.
  • Elevated RONS dysregulate critical cellular pathways, including NRF2, PI3K, MAPK, and NF-κB.
  • Dysregulation of these pathways correlates with observed anti-tumor effects like reduced proliferation, metastasis, and enhanced apoptosis.

Conclusions:

  • A comprehensive understanding of NTAP's anti-tumor mechanisms involves RONS generation and subsequent pathway modulation.
  • This systematic summary provides a foundation for advancing NTAP research and its clinical translation in oncology.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K